Mark Christopher Murray bought $77k of CE
SVP - Acetyls at Celanese Corp. 1,479 shares at an average of $52.18, traded May 23, 2025, filed May 28, 2025.
Score components
- +15RoleOfficer
- +8Trade size$77k at market
- +3Relative to holdingsHoldings up 11%
- +8Price context62% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001306830-25-000140, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 23, 2025 | POpen-market purchase Common Stock | +1,479 | $52.18 | $77k | 15,468 | May 28, 2025 |
Related signals
Other insiders at Celanese Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 52Moderate | Celanese Corp | Ganesh Moorthy director | $53k 1,000 shares | +50% | |
| 47Moderate | Celanese Corp | Deborah J. Kissire director | $54k 1,000 shares | +82% | |
| 47Moderate | Celanese Corp | Ganesh Moorthy director | $55k 1,000 shares | +100% | |
| 47Moderate | Celanese Corp | Mark Christopher Murray SVP - Acetyls | $128k 2,353 shares | +20% | |
| 56Moderate | Celanese Corp | Scott McDougald Sutton director | $407k 7,450 shares | +99% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.